6-Methyl-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
98%
- Product Code: 192723
CAS:
1182733-62-5
| Molecular Weight: | 367.39 g./mol | Molecular Formula: | C₁₇H₁₆F₃N₃OS |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 156-158 °C | Boiling Point: | 507.3±60.0 °C(Predicted) |
| Density: | 1.38±0.1 g/cm3(Predicted) | Storage Condition: | Room temperature, seal, inert gas |
Product Description:
Used as an intermediate in the synthesis of proton pump inhibitors (PPIs), particularly in the production of tenatoprazole and related compounds. It plays a key role in developing drugs that reduce gastric acid secretion, making it valuable in treating acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Its structure allows for enhanced stability and prolonged inhibition of the H+/K+-ATPase enzyme in the stomach lining, contributing to longer-lasting therapeutic effects compared to earlier PPIs. Commonly employed in research and development for next-generation acid suppressants with improved pharmacokinetic profiles.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.025 G | 10-20 days | ฿15,730.00 |
+
-
|
| 0.050 G | 10-20 days | ฿25,160.00 |
+
-
|
6-Methyl-2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)thio)-1H-benzo[d]imidazole
Used as an intermediate in the synthesis of proton pump inhibitors (PPIs), particularly in the production of tenatoprazole and related compounds. It plays a key role in developing drugs that reduce gastric acid secretion, making it valuable in treating acid-related gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome. Its structure allows for enhanced stability and prolonged inhibition of the H+/K+-ATPase enzyme in the stomach lining, contributing to longer-lasting therapeutic effects compared to earlier PPIs. Commonly employed in research and development for next-generation acid suppressants with improved pharmacokinetic profiles.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :